- Home
- TNXP vs GWH Comparison
TNXP vs GWH Comparison
Compare TNXP & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- GWH
- Stock Information
- Founded
- TNXP 2007
- GWH 2011
- Country
- TNXP United States
- GWH United States
- Employees
- TNXP N/A
- GWH N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- GWH Industrial Machinery/Components
- Sector
- TNXP Health Care
- GWH Miscellaneous
- Exchange
- TNXP Nasdaq
- GWH Nasdaq
- Market Cap
- TNXP 71.6M
- GWH 63.2M
- IPO Year
- TNXP N/A
- GWH N/A
- Fundamental
- Price
- TNXP $0.38
- GWH $5.50
- Analyst Decision
- TNXP Strong Buy
- GWH Buy
- Analyst Count
- TNXP 2
- GWH 6
- Target Price
- TNXP $53.50
- GWH $2.54
- AVG Volume (30 Days)
- TNXP 102.7M
- GWH 71.5K
- Earning Date
- TNXP 11-12-2024
- GWH 03-12-2025
- Dividend Yield
- TNXP N/A
- GWH N/A
- EPS Growth
- TNXP N/A
- GWH N/A
- EPS
- TNXP N/A
- GWH N/A
- Revenue
- TNXP $11,291,000.00
- GWH $6,241,000.00
- Revenue This Year
- TNXP $64.71
- GWH $32.11
- Revenue Next Year
- TNXP $24.49
- GWH $341.09
- P/E Ratio
- TNXP N/A
- GWH N/A
- Revenue Growth
- TNXP 183.05
- GWH 31.11
- 52 Week Low
- TNXP $0.12
- GWH $4.35
- 52 Week High
- TNXP $12.48
- GWH $16.50
- Technical
- Relative Strength Index (RSI)
- TNXP 55.72
- GWH 48.82
- Support Level
- TNXP $0.37
- GWH $5.18
- Resistance Level
- TNXP $0.58
- GWH $5.82
- Average True Range (ATR)
- TNXP 0.07
- GWH 0.41
- MACD
- TNXP 0.01
- GWH 0.01
- Stochastic Oscillator
- TNXP 43.06
- GWH 50.08
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.